WASHINGTON – Consumer Healthcare Products Association (CHPA) president and CEO Scott Melville released the below statement Friday in response to a recent report published in the Journal of the American Medical Association (JAMA): “There can be no tolerance for illegal products masquerading as dietary supplements, especially after a manufacturer has already received an FDA warning letter.
WASHINGTON — CHPA’s president and CEO, Scott Melville, today released the following statement in response to news of HRA Pharma’s application to the U.S. Food and Drug Administration (FDA) for the first-ever over-the-counter (OTC) birth control pill in the United States: “CHPA is pleased to see the Rx-to-OTC switch pathway being used to broaden access to
WASHINGTON — CHPA’s president and CEO, Scott Melville, released the following statement in response to the introduction of the FDA Safety and Landmark Advancement (FDASLA) Act of 2022: “CHPA has been consistent in its support of the policy of Mandatory Product Listing (MPL) for dietary supplements, but we remain extremely concerned with the provisions contained
WASHINGTON — CHPA president and CEO Scott Melville released the following statement in response to Senator Durbin’s and Senator Braun’s Introduction of the Dietary Supplement Listing Act of 2022: “CHPA appreciates the work of Senators Durbin and Braun and their focus on updating the 28-year-old Dietary Supplement Health and Education Act (DSHEA) of 1994. It
WASHINGTON — The Consumer Healthcare Products Association (CHPA) issued the following statement from president and CEO Scott Melville regarding the Food and Drug Administration’s (FDA) fiscal year 2023 budget request: “FDA’s recent request for a 34 percent budget increase in FY2023 shows that new FDA Commissioner Robert Califf recognizes the critical importance of self-care in
WASHINGTON — The Consumer Healthcare Products Association (CHPA) issued the following statement Tuesday from Scott Melville, president and CEO, regarding the confirmation of Dr. Robert Califf, as the new U.S. Food and Drug Administration (FDA) commissioner: “Dr. Califf is a highly respected clinician and researcher with an outstanding record of public service, including previously serving
WASHINGTON — The Consumer Healthcare Products Association (CHPA) issued the following statement today from Scott Melville, president and CEO, regarding the nomination of Dr. Robert Califf as the next U.S. Food and Drug Administration (FDA) commissioner. Dr. Califf is a prominent cardiologist and researcher who served as the FDA commissioner under President Barack Obama. “CHPA
WASHINGTON — To combat teen abuse of over-the-counter (OTC) medicines containing the cough suppressant dextromethorphan (DXM), Ohio Governor Mike DeWine today signed into law HB 9, prohibiting the sale of DXM-containing products to minors without a prescription. The law will take effect on September 29, 2021. Ohio’s new law comes on the heels of the
NEW HOPE – The Consumer Healthcare Products Association (CHPA) today announced the election of Michelle Wang Goodridge as the new Chair of the CHPA board of directors. Goodridge was elected on June 16th, along with six new board members, at CHPA’s annual membership meeting held during the association’s new Self-Care Leadership Summit. Goodridge, a standing
WASHINGTON – The Consumer Healthcare Products Association (CHPA), the national trade association representing leading manufacturers in the personal healthcare products industry, welcomes Church & Dwight, Bridges Consumer Healthcare, and Rhinomed as its newest manufacturer members of the association. The three companies play an important role in personal healthcare with product offerings that include over-the-counter (O-T-C)
Despite the difficult realities of COVID-19, and the tremendous challenge, pain and uncertainty it has created, 2020 was also a year of incredible progress for self-care in the United States. From manufacturers to retailers, we at Consumer Healthcare Products Association are proud of the pivotal role our extended industry has played in providing and maintaining
